| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/1998 | CA2210597A1 Buprenorphine percutaneous absorption preparation |
| 01/18/1998 | CA2195606A1 Method of increasing efficacy of cancer drugs |
| 01/17/1998 | CA2210600A1 Inhibitor of tumor metastasis or recurrence |
| 01/15/1998 | WO1998001740A2 Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of a lim-kinase gene |
| 01/15/1998 | WO1998001571A2 Erythromycins and process for their preparation |
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001549A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | WO1998001547A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 01/15/1998 | WO1998001546A2 Polyketides and their synthesis |
| 01/15/1998 | WO1998001454A1 Process for the preparation of platinum compounds |
| 01/15/1998 | WO1998001450A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 01/15/1998 | WO1998001449A1 Novel compounds |
| 01/15/1998 | WO1998001447A1 Pyridyl-piperazinyl-phenyl-oxazolidinone derivatives and their use as antibacterials |
| 01/15/1998 | WO1998001446A1 Substituted piperazinyl-phenyl-oxazolidinone derivatives and their use as anti-bacterial agents |
| 01/15/1998 | WO1998001445A1 Indole derivatives for the treatment of osteoporosis |
| 01/15/1998 | WO1998001444A1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/15/1998 | WO1998001440A2 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof |
| 01/15/1998 | WO1998001436A1 Heteroaromatic pentadienoic acid derivatives useful as inhibitors of bone resorption |
| 01/15/1998 | WO1998001428A1 AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN |
| 01/15/1998 | WO1998001426A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 01/15/1998 | WO1998001425A1 1,4-di-sustituted piperidines as muscarinic antagonists |
| 01/15/1998 | WO1998001423A1 5-indolyl-2,4-pentadienoic acid derivatives useful as inhibitors of bone resorption |
| 01/15/1998 | WO1998001422A1 New amidino derivatives and their use as thrombin inhibitors |
| 01/15/1998 | WO1998001420A1 4(4-oxocyclohexyl) benzamides as intermediate products for medicaments |
| 01/15/1998 | WO1998001417A1 Calcium receptor-active compounds |
| 01/15/1998 | WO1998001159A2 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | WO1998001156A2 Method for producing chlorins and bacteriochlorins containing polyether |
| 01/15/1998 | WO1998001146A1 Preventives/remedies for stomatitis |
| 01/15/1998 | WO1998001139A1 Injections containing lipid a analogues and process for the preparation thereof |
| 01/15/1998 | WO1998001137A1 The ocular hypotensive active compositions |
| 01/15/1998 | WO1998001136A1 Formulations of vesicant drugs and methods of use thereof |
| 01/15/1998 | WO1998001135A1 Phosphorus eliminants, serum parathormone level increase inhibit ors, and osteodystrophy inhibitors |
| 01/15/1998 | WO1998001134A1 Oral pharmaceutical combinations of antihistaminic compounds and terpenoids |
| 01/15/1998 | WO1998001132A1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 01/15/1998 | WO1998001130A1 Remedies for ischemic diseases |
| 01/15/1998 | WO1998001129A1 Preventives or remedies for neurodegenerative diseases |
| 01/15/1998 | WO1998001128A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/15/1998 | WO1998001127A1 Veterinary use of a pleuromutilin derivative |
| 01/15/1998 | WO1998001125A2 Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity |
| 01/15/1998 | WO1998001124A2 Pharmaceutical preparation containing nimesulide for topical use |
| 01/15/1998 | WO1998001123A1 Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression |
| 01/15/1998 | WO1998001122A1 Solid dispersions or solid dispersion preparations of tricyclic compounds |
| 01/15/1998 | WO1998001121A1 P/q type calcium channel antagonist |
| 01/15/1998 | WO1998001120A1 Method of inhibiting nadph oxidase |
| 01/15/1998 | WO1998001119A2 Pharmaceutical compositions comprising simvastatin |
| 01/15/1998 | WO1998001118A1 Pharmaceutical composition for oral delivery |
| 01/15/1998 | WO1998001117A1 Sustained release matrix for high-dose insoluble drugs |
| 01/15/1998 | WO1998001116A1 Therapy for combined hyperlipidemia |
| 01/15/1998 | WO1998001115A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 01/15/1998 | WO1998001112A1 New use of a hydrogel formulation |
| 01/15/1998 | WO1998001111A1 Transdermal compositions containing levosimendan |
| 01/15/1998 | WO1998001101A2 Methods for the treatment of apolipoprotein e related diseases |
| 01/15/1998 | WO1998001100A2 Method for treating homozygous familial hypercholesterolemia |
| 01/15/1998 | WO1998001099A2 Method of treating retinal ischemia and glaucoma |
| 01/15/1998 | WO1997046673A3 Inhibition of hiv-1 replication by antisense rna expression |
| 01/15/1998 | WO1997040166A3 Simian-human hav having a chimeric 2c protein |
| 01/15/1998 | WO1997039759A3 Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | DE19646977A1 Stable dry extract of Hypericum perforatum L., Saint John's wort |
| 01/15/1998 | DE19629468A1 Transdermale therapeutische Systeme Transdermal therapeutic systems |
| 01/15/1998 | DE19628335A1 Use of topical (carbazolyl-oxy)-propanolamine derivatives |
| 01/15/1998 | DE19627421A1 Use of (carboxy- or tetrazolyl-bi:phenyl)methyl)pyridone compounds |
| 01/15/1998 | CA2741501A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 01/15/1998 | CA2260190A1 New amidino derivatives and their use as thrombin inhibitors |
| 01/15/1998 | CA2260183A1 Methods for the treatment of apolipoprotein e related diseases |
| 01/15/1998 | CA2260128A1 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof |
| 01/15/1998 | CA2260057A1 Novel compounds |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259895A1 The ocular hypotensive active compositions |
| 01/15/1998 | CA2259618A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | CA2259573A1 Amidinoindoles, amidinoazoles, and analogs thereof as inhibitors of factor xa and of thrombin |
| 01/15/1998 | CA2259504A1 4(4-oxocyclohexyl) benzamides as intermediate products for medicaments |
| 01/15/1998 | CA2259463A1 Polyketides and their synthesis |
| 01/15/1998 | CA2258525A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 01/15/1998 | CA2258052A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 01/15/1998 | CA2257563A1 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | CA2207141A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/15/1998 | CA2207083A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/14/1998 | EP0818459A2 Carbohydrate derivatives |
| 01/14/1998 | EP0818454A1 Benzimidazole derivatives with antihistaminic activity |
| 01/14/1998 | EP0818453A1 Benzothiophene compounds and methods of use |
| 01/14/1998 | EP0818449A1 2-(1H)-quinolone derivatives as antagonists of excitatory amino acids |
| 01/14/1998 | EP0818448A1 Cycloalkano-pyridine as CETP inhibitors |
| 01/14/1998 | EP0818447A1 6-(Hydroxymethyl-ethyl)pyridines as HMG-CoA-reductase inhibitors |
| 01/14/1998 | EP0818443A2 Mercaptoketones and mercaptoalcohols, a process for their preparation and their use as inhibitors of matrix metalloproteinases |
| 01/14/1998 | EP0818442A2 Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor |
| 01/14/1998 | EP0818207A2 Medical article |
| 01/14/1998 | EP0818201A1 Use of a polysaccharide to stimulate immune defenses |
| 01/14/1998 | EP0818200A1 Use of polysaccharide to stimulate desquamation of the skin and compositions containing it |
| 01/14/1998 | EP0818199A1 Drug containing methotrexate derivative |
| 01/14/1998 | EP0818198A1 Potentiation of drug response by increasing serotonin availability |
| 01/14/1998 | EP0818197A1 Heterocyclic condensed pyridines as CETP inhibitors |
| 01/14/1998 | EP0818196A1 Food or drink containing dioxabicyclo (3.3.0) octane compounds |
| 01/14/1998 | EP0817969A1 Inhibition of tau-tau-association |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817787A1 Nitrogenous macrocyclic compounds |
| 01/14/1998 | EP0817786A1 Substituted tetronic acids useful for treating hiv and other retroviruses |
| 01/14/1998 | EP0817784A1 Process for the synthesis of nucleoside analogues |
| 01/14/1998 | EP0817782A1 Phenyl derivatives useful as endothelin receptor antagonists |
| 01/14/1998 | EP0817780A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |